Leading COVID-19 vaccine developer AstraZeneca agreed on Saturday to buy Boston pharmaceutical firm Alexion for US$39 billion.
Source: ctv business
COVID-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for US billion
We are here to help you!
Phone ; 1 844-748-LOAN (5626)